A Validation and Dosimetry Study of GSK2634673F PET Ligand

Clinical trial NCT02052297 · TERMINATED

Trial details

NCT number: NCT02052297
Sponsor: GlaxoSmithKline
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Idiopathic Pulmonary Fibrosis

Start date: 2014-01-24
Primary completion: 2016-04-21
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.